US Stock MarketDetailed Quotes
ALLR Allarity Therapeutics
- 1.2500
- -0.0100-0.79%
Trading Nov 22 14:59 ET
5.54MMarket Cap-177P/E (TTM)
1.2800High1.2250Low56.69KVolume1.2600Open1.2600Pre Close71.49KTurnover1.28%Turnover Ratio0.00P/E (Static)4.43MShares666.000052wk High0.43P/B5.54MFloat Cap1.150052wk Low--Dividend TTM4.43MShs Float15288000.0000Historical High--Div YieldTTM4.37%Amplitude1.1500Historical Low1.2610Avg Price1Lot Size
About Allarity Therapeutics Company
Allarity Therapeutics, Inc. engages in the development of drugs for personalized treatment of cancer guided by its proprietary Drug Response Predictor (DRP) technology. The company operates in two geographic areas: Denmark and the United States. The company was founded on April 4, 2021 and is headquartered in Boston, MA.
Company Profile
SymbolALLR
Company NameAllarity Therapeutics
Listing DateDec 21, 2021
Founded2021
CEOMr. Thomas H. Jensen
MarketNASDAQ
Employees6
Fiscal Year Ends12-31
Address24 School Street,2nd floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02108
Phone1-401-426-4664
Websitehttp://www.allarity.com
Company Executives
- Name
- Position
- Salary
- Thomas H. Jensen
- Chief Executive Officer and Director
- 24.72K
- Dr. Jeremy Graff, PhD
- President and Chief Development Officer
- --
- Alexander Epshinsky
- Chief Financial Officer
- --
- Dr. Steen Knudsen, PhD
- Chief Scientific Officer
- 266.22K
- Joan Y. Brown
- Director, Financial Reporting and Principal Accounting Officer
- 250.00K
- Gerald W. McLaughlin
- Chairman of the Board
- 107.38K
- Joseph W. Vazzano, C.P.A.
- Independent Director
- 29.17K
- Dr. Laura E. Benjamin, PhD
- Independent Director
- 27.71K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data